Decartes-08 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-11-30 in 4mo
ESTIMATED |
READOUT
Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential
Phase 3 · Myasthaenia Gravis |
RNAC Cartesian Therapeutics, Inc. | Decartes-08 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|